
Glenmark Pharma shares jump 20% to hit record high after cancer drug licensing deal with AbbVie
Shares of Glenmark Pharmaceuticals Ltd surged 20 per cent in Friday's trade, hitting a new all-time high of Rs 2,286.15 apiece, after the company announced a major licensing agreement involving its innovation subsidiary. The counter saw heavy trading …